Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00176293
Recruitment Status : Terminated (Slow accrual)
First Posted : September 15, 2005
Last Update Posted : April 21, 2015
Ortho Biotech, Inc.
Information provided by:
University of Kentucky

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2007
  Actual Study Completion Date : February 2007